Humoral and cellular immune responses after SARSCoV-2-Vaccination in a Swedish cohort of persons with multiple sclerosis treated with disease modifying therapiesShow others and affiliations
2022 (English)In: Multiple Sclerosis Journal, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 28, no 3_SUPPL, p. 103-104Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Sage Publications, 2022. Vol. 28, no 3_SUPPL, p. 103-104
National Category
Neurology
Identifiers
URN: urn:nbn:se:kth:diva-322334ISI: 000866540800135OAI: oai:DiVA.org:kth-322334DiVA, id: diva2:1719423
Conference
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, OCT 26-28, 2022, Amsterdam, NETHERLANDS
Note
QC 20221215
2022-12-152022-12-152022-12-15Bibliographically approved